Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for generic pharma products
Interim injunctions and preliminary issues cannot be divorced in latest generic pain dispute before Mr Justice Arnold Interim injunctions and preliminary issues cannot be divorced in latest generic pain dispute before Mr Justice Arnold Reviewed by Annsley Merelle Ward on Sunday, March 13, 2016 Rating: 5
Letter from AmeriKat: Hospira's Angiomax win, Apple jury award vacated & Obama's Pacific trade deal Letter from AmeriKat: Hospira's Angiomax win, Apple jury award vacated & Obama's Pacific trade deal Reviewed by Annsley Merelle Ward on Sunday, July 12, 2015 Rating: 5
Letter from AmeriKat: Will narrowing innovator-generic price gap change IP law? Letter from AmeriKat: Will narrowing innovator-generic price gap change IP law? Reviewed by Annsley Merelle Ward on Monday, March 16, 2015 Rating: 5
AIPPI Congress Report 4: Should Europe embrace a patent linkage system? AIPPI Congress Report 4: Should Europe embrace a patent linkage system? Reviewed by Annsley Merelle Ward on Wednesday, September 17, 2014 Rating: 5
CJEU declares Poland's law on cheap drugs contrary to EU Law CJEU declares Poland's law on cheap drugs contrary to EU Law Reviewed by Darren Smyth on Monday, April 02, 2012 Rating: 5
“[T]he issue of principle . . . is that there is no issue of principle.” “[T]he issue of principle . . . is that there is no issue of principle.” Reviewed by Norman on Monday, March 19, 2012 Rating: 5
A new battleground of innovative and generic drug manufacturers? A new battleground of innovative and generic drug manufacturers? Reviewed by Norman on Friday, February 10, 2012 Rating: 5
That WTO complaint: a Kat is mildly puzzled That WTO complaint: a Kat is mildly puzzled Reviewed by Jeremy on Friday, May 14, 2010 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.